| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN1355171B Extracting process and usage of general aralic chinensis saponin |
| 01/19/2011 | CN101952414A Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) |
| 01/19/2011 | CN101952321A Recombinant RSV antigens |
| 01/19/2011 | CN101952291A 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-B[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases PLK41 to PLK4 for the treatment of proliferative diseases |
| 01/19/2011 | CN101952285A Amino triazoles as PI3K inhibitors |
| 01/19/2011 | CN101951956A Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 01/19/2011 | CN101951952A Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 01/19/2011 | CN101951940A Treatment of autoimmune disorders |
| 01/19/2011 | CN101951931A Immunomodulating compositions and uses therefor |
| 01/19/2011 | CN101951911A 2-amino purine derivatives and their use as anti-herpetic agents |
| 01/19/2011 | CN101948729A Deer turtle ginseng wine and preparation method thereof |
| 01/19/2011 | CN101948549A Sulphating modification method of gynostemma pentaphylla polysaccharide |
| 01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948470A Application of phenanthroindolizidine alkaloid organic acid salt derivative in medicine |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101947315A Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947261A Method for preparing traditional Chinese medicinal composition for postoperative recovery in concurrent chemoradiotherapy |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947233A Compound medicinal composition for treating livestock and poultry respiratory disease and soluble powder thereof |
| 01/19/2011 | CN101947218A Method for modulating calcium ion-release-activated calcium ion channels |
| 01/19/2011 | CN101947216A Application of andrographolidume to preparing medicine for treating acute liver injury |
| 01/19/2011 | CN101947213A Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls |
| 01/19/2011 | CN101544654B Dimer (5-methylol-furfural), synthetic method thereof and medical application thereof |
| 01/19/2011 | CN101536997B Application of ginseng alkynol in pharmacy |
| 01/19/2011 | CN101485626B Aqueous solution containing coenzyme Q10 nano granule and preparation method thereof |
| 01/19/2011 | CN101401813B Panaxatriol saponin composition and uses in preparing medicament for immunity enhancement |
| 01/19/2011 | CN101298471B Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof |
| 01/19/2011 | CN101284115B Kidney-tonifying and body-strengthening pellet |
| 01/19/2011 | CN101156947B Ginseng source peptide albumen, its preparing method and application |
| 01/19/2011 | CN101092397B Structure modified compound of sinomenine, and prepartion method |
| 01/19/2011 | CN101011419B Propolis preparation and its preparation method |
| 01/18/2011 | US7872151 Inhibitors of α4 mediated cell adhesion |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872025 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/18/2011 | US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2441964C New pharmaceutical compositions based on anticholinergics and endothelin antagonists |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/18/2011 | CA2189055C Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 01/13/2011 | WO2011006029A1 Artificial cell constructs for inducing immunological tolerance |
| 01/13/2011 | WO2011005871A1 Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists |
| 01/13/2011 | WO2011005715A1 Diagnosis and treatment of autoimmune demyelinating diseases |
| 01/13/2011 | WO2011005523A2 Galectin-immunoglobulin chimeric molecules |
| 01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
| 01/13/2011 | WO2011004282A2 Novel polymorphic form of teriflunomide salts |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003138A1 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| 01/13/2011 | WO2010094720A3 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009478 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
| 01/13/2011 | US20110009477 Oligonucleotide-based compounds as inhibitors of toll-like receptors |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009429 Heterocyclic compounds as inhibitors of cxcr2 |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009340 Combination of an iron chelator and an immunosuppressant and use thereof |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009325 Crystalline forms of rapamycin analogs |
| 01/13/2011 | US20110008451 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 01/13/2011 | US20110008426 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 01/13/2011 | US20110008417 Immunomodulating compositions and uses therefor |
| 01/13/2011 | US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 01/13/2011 | US20110008394 Active substances that increase the activation threshold of immune cells |
| 01/13/2011 | US20110008392 Vaccine targets and delivery systems for cryptosporidium |
| 01/13/2011 | US20110008390 Production of a Viable, Storable Worm Egg Suspension |
| 01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
| 01/13/2011 | US20110008388 Piglet feed rations having low levels of fermentable carbohydrates |